data/exclude_pages.json

{
  "2019_Evolution-of-CDM-to-CDS-Part-1-Drivers.pdf": [1, 2, 22],
  "2020_Evolution-of-CDM-to-CDS-Part-2-Technology-Enablers.pdf": [1, 2, 29, 30],
  "2020_Evolution-of-CDM-to-CDS-Part-3-Evolution-of-CDM-Role.pdf": [1, 2, 30],
  "E8-R1_Guideline_Step4_2021_1006.pdf": [1, 2, 3, 4, 5, 6],
  "ICH_E6(R3)_Step4_FinalGuideline_2025_0106.pdf": [1, 2, 3, 4, 5, 6, 7],
  "SCDM-Automation-of-CDM-Driven-Activities-FINAL.pdf": [1, 11],
  "SCDM-rb-CDM-July-6th.pdf": [1, 10],
  "SCDM-The-5Vs-of-Clinical-Data-FINAL.pdf": [1, 9],
  "SCDM-The-evolution-of-Clinical-Data-Review-FINAL.pdf": [1],
  "SCDM-Topic-Brief-The-CDM-Role-Evolution-FINAL.pdf": [1, 9],
  "Short-Brief-DCT.pdf": [1],
  "Topic Brief on eSource: Playbook 1: Practical advice for vendors and CROs.pdf": [1, 9],
  "Topic Brief on eSource: Playbook 2: Taking a sites eye view.pdf": [1, 10],
  "Topic Brief on eSource: Playbook 3: Practical advice for pharma.pdf": [1, 10],
  "Topic Brief on eSource: Playbook 4: A personal regulatory view.pdf": [1, 7]
}